The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
President Donald Trump baselessly blamed a diversity program for the crash. Meta CEO Mark Zuckerberg said the company is still committed to diversity.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...